Joke Regts
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Lipid Membrane Structure and Behavior 12
- Epidemiology 15
- Herpesvirus Infections and Treatments 7
- Hepatitis B Virus Studies 6
- Co-authors
- Gerrit L. Scherphof (17 shared papers)Jan Wilschut (17 shared papers)Jan Damen (3 shared papers)Toos Daemen (21 shared papers)Frits H. Roerdink (5 shared papers)Annelies Riezebos‐Brilman (6 shared papers)Bert Dontje (4 shared papers)Laura Bungener (3 shared papers)
- Journals
- Biochimica et Biophysica Acta (BBA) - Biomembranes (8 papers)Gene Therapy (5 papers)Vaccine (4 papers)FEBS Letters (3 papers)Antiviral Therapy (2 papers)
- Partner nations
- NetherlandsUnited StatesSweden
In The Last Decade
Joke Regts
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Biomaterials 274
- Immunology 366
- Biochemistry 109
- Molecular Biology 694
- Hepatology 73
Countries citing papers authored by Joke Regts
This map shows the geographic impact of Joke Regts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joke Regts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joke Regts more than expected).
Fields of papers citing papers by Joke Regts
This network shows the impact of papers produced by Joke Regts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joke Regts. The network helps show where Joke Regts may publish in the future.
Co-authors
The 25 scholars most cited alongside Joke Regts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 136 | |
| 2 | 1981 | 134 | |
| 3 | 1978 | 107 | |
| 4 | 1986 | 73 | |
| 5 | 1997 | 70 | |
| 6 | 1999 | 70 | |
| 7 | 2003 | 64 | |
| 8 | 1984 | 63 | |
| 9 | 2004 | 57 | |
| 10 | 1997 | 54 | |
| 11 | 2002 | 54 | |
| 12 | 1997 | 47 | |
| 13 | 2000 | 39 | |
| 14 | 1979 | 39 | |
| 15 | 2005 | 33 | |
| 16 | 1979 | 32 | |
| 17 | 1989 | 29 | |
| 18 | 2007 | 28 | |
| 19 | 1980 | 27 | |
| 20 | 2013 | 25 |
About Joke Regts
Joke Regts is a scholar working on Molecular Biology, Epidemiology, Immunology, Oncology and Physiology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (12 papers), Immunotherapy and Immune Responses (11 papers), Herpesvirus Infections and Treatments (7 papers), Hepatitis B Virus Studies (6 papers), Drug Transport and Resistance Mechanisms (4 papers), Virus-based gene therapy research (3 papers), Biomedical Research and Pathophysiology (3 papers) and Erythrocyte Function and Pathophysiology (3 papers). The work is most often cited by research in Biomaterials (274 citations), Immunology (366 citations), Biochemistry (109 citations), Molecular Biology (694 citations) and Hepatology (73 citations). Joke Regts has collaborated with scholars based in Netherlands, United States and Sweden. Frequent co-authors include Gerrit L. Scherphof, Jan Wilschut, Jan Damen, Toos Daemen, Frits H. Roerdink, Annelies Riezebos‐Brilman, Bert Dontje, Laura Bungener, Halbe H. Spanjer and Mieke van Galen. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Gene Therapy, Vaccine, FEBS Letters and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.